Natalie Staplin

Natalie Staplin

University of Oxford

H-index: 34

Europe-United Kingdom

Contact Natalie Staplin

About Natalie Staplin

Natalie Staplin, With an exceptional h-index of 34 and a recent h-index of 32 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Population Health, Epidemiology, Statistics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

Design, recruitment and baseline characteristics of the LENS trial

Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the EMPA-KIDNEY trial

Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Natalie Staplin Information

University	University of Oxford
Position	Senior Statistician Nuffield Department of Population Health
Citations(all)	18402
Citations(since 2020)	18052
Cited By	3953
hIndex(all)	34
hIndex(since 2020)	32
i10Index(all)	51
i10Index(since 2020)	50
Email	Access Email
University Profile Page	University of Oxford
Google Scholar	View Google Scholar Profile

Natalie Staplin Skills & Research Interests

Population Health

Epidemiology

Statistics

Top articles of Natalie Staplin

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

The Lancet Child & Adolescent Health

2024/3/1

Christine E Jones

H-Index: 12

Natalie Staplin

H-Index: 20

Elizabeth Whittaker

H-Index: 4

Thomas Jaki

H-Index: 25

Adam Finn

H-Index: 22

Paul Fleming

H-Index: 13

Marieke Emonts

H-Index: 17

Dominic Kelly

H-Index: 2

Nazima Pathan

H-Index: 16

Patrick Davies

H-Index: 50

Malcolm G Semple

H-Index: 37

Marian Knight

H-Index: 57

Aparna Mukherjee

H-Index: 1

Guy Thwaites

H-Index: 61

Lucy Chappell

H-Index: 42

Jeremy Day

H-Index: 28

Design, recruitment and baseline characteristics of the LENS trial

Nephrology Dialysis Transplantation

2022/7

Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial

European Heart Journal

2024/2/2

Raja Jayaram

H-Index: 9

Zhengming Chen

H-Index: 25

Natalie Staplin

H-Index: 20

Michael Hill

H-Index: 37

Barbara Casadei

H-Index: 42

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

The Lancet Diabetes & Endocrinology

2024/1/1

Natalie Staplin

H-Index: 20

Christoph Wanner

H-Index: 12

David Preiss

H-Index: 40

Alistair J Roddick

H-Index: 5

Michael Hill

H-Index: 37

J Li

H-Index: 9

D Cherney

H-Index: 16

A Awad

H-Index: 4

Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure

Hypertension

2024/4/25

Tobias Fehlmann

H-Index: 20

Natalie Staplin

H-Index: 20

Bryan Williams

H-Index: 2

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the EMPA-KIDNEY trial

The Lancet Diabetes & Endocrinology

2024/1/1

J Li

H-Index: 9

D Cherney

H-Index: 16

A Awad

H-Index: 4

Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Circulation

2024/4/7

Milton Packer

H-Index: 81

Natalie Staplin

H-Index: 20

Christoph Wanner

H-Index: 12

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Nature Communications

2024/1/31

Adilia Warris

H-Index: 34

S Das

H-Index: 9

A blunted nocturnal blood pressure decline is associated with all-cause and cardiovascular mortality.

Journal of Hypertension

2024/3/6

Natalie Staplin

H-Index: 20

Colin Baigent

H-Index: 74

Bryan Williams

H-Index: 2

Ambulatory blood pressure monitoring and mortality–Authors' reply

2024/3/2

Natalie Staplin

H-Index: 20

Colin Baigent

H-Index: 74

Bryan Williams

H-Index: 2

Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials

Clinical Journal of the American Society of Nephrology

2024/1/24

Rajiv Agarwal

H-Index: 51

Natalie Staplin

H-Index: 20

Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease

Journal of the American Society of Nephrology

2024/1/15

Natalie Staplin

H-Index: 20

Christoph Wanner

H-Index: 12

David Preiss

H-Index: 40

John Nolan

H-Index: 19

Roberto Pontremoli

H-Index: 29

Jennifer S Lees

H-Index: 9

Patrick B Mark

H-Index: 34

Simon J Davies

H-Index: 33

191 Mechanisms and predictors of acute kidney injury with perioperative rosuvastatin in patients undergoing cardiac surgery

2023/6/1

Zhengming Chen

H-Index: 25

Raja Jayaram

H-Index: 9

Natalie Staplin

H-Index: 20

Barbara Casadei

H-Index: 42

Michael Hill

H-Index: 37

Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors

Kidney International

2023/4/1

Daniel Chapman

H-Index: 25

Natalie Staplin

H-Index: 20

Thomas Arnold

H-Index: 3

Colin Baigent

H-Index: 74

Michael Hill

H-Index: 37

Sarah Clark

H-Index: 3

WCN23-0342 DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL

Kidney International Reports

2023/3/1

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet Diabetes & Endocrinology

2023/12/1

A Abdullah

H-Index: 3

B Ahmed

H-Index: 4

R Ahmed

H-Index: 18

Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity

Nature communications

2023/11/15

James Scott-Brown

H-Index: 6

Rishi Gupta

H-Index: 13

David Harrison

H-Index: 14

Jake Dunning

H-Index: 22

Natalie Staplin

H-Index: 20

Malcolm G Semple

H-Index: 37

The kidney failure risk equation: evaluation of novel input variables including eGFR estimated using the CKD-EPI 2021 equation in 59 cohorts

Journal of the American Society of Nephrology

2023/3/1

Kunihiro Matsushita

H-Index: 58

Simon Sawhney

H-Index: 11

Manish M Sood

H-Index: 31

Natalie Staplin

H-Index: 20

Jan Van Den Brand

H-Index: 8

Mark Woodward

H-Index: 16

Jae Won Yang

H-Index: 7

Mendelian randomization study of the relevance of blood pressure to vascular mortality among 150,000 participants in the mexico city prospective study

European Heart Journal

2023/11

Mechanisms and Predictors of Acute Kidney Injury with Perioperative Rosuvastatin in Patients Undergoing Cardiac Surgery

medRxiv

2023/2/10

See List of Professors in Natalie Staplin University(University of Oxford)

academic-engine

Useful Links

List of top 50 universities

List of top 100 universities

List of top 500 universities

Find Professors Email

Find Universities Email

CUFinder Academic Engine